Rush Heart

To Treat or Not to Treat: Cardiovascular Management Considerations in the Cardio-Oncology Patient

By Rush Heart
By Rush Heart
810 views
May 5, 2017
Cardiology Grand Rounds:

To Treat or Not to Treat: Cardiovascular Management Considerations in the Cardio-Oncology ...
read more ↘
Comments 0
Login to view comments. Click here to Login

Recommended

57:30

Five Things Every Internist Should Know About Anticoagulants

McMaster University Department of Medicine

S. Mithoowani

5.5K views
19:28

Perioperative Considerations for Anticoagulation With Mechanical Dev…

James Douketis

116 views
15:24

Managing Complications of Dermatologic Surgery

Masterclasses in Dermatology

D. Siegel

86 views
10:21

Mechanical Microvascular Protection is Not Needed with the Right Pha…

Tim Fischell

581 views
22:08

Antithrombotic Pharmacology in ACS PCI: What’s Practical, What’s in …

Scottsdale Interventional Forum 2013

R. Harrington

827 views
14:39

Management of AF patients with ACS

Lankenau

P. Kowey, D. Ice

11.4K views
17:19

Essentials of ACS/PCI Pharmacology: An Overview and Approach

Scottsdale Interventional Forum 2014

R. Harrington

1.7K views
41:22

Friday Lunch - Conversations in Cardiology Featuring Morton J Kern

Scottsdale Interventional Forum 2014

M. Kern

310 views
18:23

Anticoagulation After LAA Closure

Congenital and Structural Interventions

M. Bergmann

863 views
16:55

PCI Pharmacology in 2015: Choosing the Right Antiplatelet & Anticoag…

Scottsdale Interventional Forum 2015

S. Bailey

1.8K views
14:17

Beyond ISAR Triple: Optimal Triple Drug Therapy After DES Implantati…

Scottsdale Interventional Forum 2015

M. Kutcher

870 views
12:55

Update on PCI Pharmacology: What the Interventionalist needs to know…

Scottsdale Interventional Forum 2016

S. Bailey

540 views
15:38

What is the Role of Left Atrial Appendage Therapies in Comparison to…

Scottsdale Interventional Forum 2016

475 views
15:31

Acute Coronary Syndrome Update

ARCH Advanced Revascularization Symposium

R. Bach

355 views
11:53

Bivalirudin, IIB/IIA Inhibitors, UFH and DAPT Cocktails For STEMI

Emory Practical Intervention Course – Southeastern Consortium (EPIC-SEC) 2015

D. Angiolillo

67 views
19:14

Is Coumadin Dead? Are Novel Anticoagulant Drugs the Optimal Therapy?…

Cardiology Fiesta 2016

B. Kalich

423 views
11:59

Bivalirudin vs. Heparin

ARCH Advanced Revascularization Symposium

A. Amin

55 views
10:29

Bivalirudin vs. Heparin

ARCH Advanced Revascularization Symposium

D. Cox

37 views
10:32

New Antiplatelet Agents

Complex Coronary Valvular and Vascular Cases Conference

11 views
24:51

DAPT Durations – How Long is Enough?

Northwell Health Cardiovascular Fellows Course 2018

C. Grines

564 views
AUTOPLAY